Flagship Pioneering’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-797,720
| Closed | -$18M | – | 10 |
|
|
2023
Q2 | $18M | Sell |
797,720
-1
| -0% | -$23 | 0.8% | 7 |
|
|
2023
Q1 | $9.65M | Hold |
797,721
| – | – | 0.37% | 8 |
|
|
2022
Q4 | $3.63M | Hold |
797,721
| – | – | 0.12% | 10 |
|
|
2022
Q3 | $5.19M | Hold |
797,721
| – | – | 0.22% | 11 |
|
|
2022
Q2 | $8.61M | Hold |
797,721
| – | – | 0.32% | 10 |
|
|
2022
Q1 | $15.2M | Hold |
797,721
| – | – | 0.36% | 12 |
|
|
2021
Q4 | $28.6M | Hold |
797,721
| – | – | 0.44% | 11 |
|
|
2021
Q3 | $58.6M | Hold |
797,721
| – | – | 0.61% | 10 |
|
|
2021
Q2 | $111M | Hold |
797,721
| – | – | 1.42% | 9 |
|
|
2021
Q1 | $232M | Hold |
797,721
| – | – | 3.71% | 6 |
|
|
2020
Q4 | $498M | Buy |
+797,721
| New | +$498M | 9.07% | 2 |
|